PHI with Urinary tract stones
How does this condition affect your private health insurance?
Harnorgansteine, or urolithiasis, are hard deposits formed from minerals and salts in the urinary tract, including kidneys, ureters, and bladder. They can cause excruciating renal colic pain, often radiating to the back and abdomen, accompanied by nausea, vomiting, and hematuria (blood in urine). Causes include dehydration, dietary factors, genetics, and metabolic conditions. If a stone obstructs the urinary flow, it can lead to severe complications such as infection, hydronephrosis, and potential kidney damage. Treatment ranges from conservative management with pain relief and hydration to medical expulsive therapy, lithotripsy (shock wave or laser), or surgical removal, depending on stone size and location.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Hours to several days, depending on stone passage or intervention.
Duration of Illness (Lifetime)
Recurrent episodes; a chronic condition for many, requiring ongoing management and prevention.
Cost of Treatment (Initial)
Highly variable, from several hundred for conservative management to several thousand for procedures like lithotripsy or ureteroscopy (e.g., €500 - €10,000+).
Cost of Treatment (Lifetime)
Significantly higher due to potential recurrences and follow-up care, potentially tens of thousands over a lifetime (e.g., €5,000 - €50,000+).
Mortality Rate
Very low, primarily associated with severe, untreated complications like urosepsis in obstructed kidneys (<1%).
Risk of Secondary Damages
Moderate, including kidney damage (hydronephrosis, reduced kidney function) if untreated, and increased risk of urinary tract infections (10-30%).
Probability of Full Recovery
High for resolution of the acute episode (over 90%), but recurrence is common if preventative measures are not taken.
Underlying Disease Risk
Moderate, associated with metabolic syndrome, diabetes, obesity, hyperparathyroidism, gout, and certain kidney diseases (10-25% have an identifiable metabolic cause).